Articles tagged Research Funding
(55 results)

The U.S. has long been a global leader in science, but that position is at risk. As research funding drops and political pressures rise, scientists, particularly in academia and research institutes, are at a crossroads—what will happen to their labs and their research? Innovation is slowing, and the next generation of researchers is being driven out. Without renewed support, the future of American science and the benefits it brings to our nation could be lost.

In the Paths to Science Policy series, we talk to individuals who have a passion for science policy and are active in advocacy through their various roles and careers. The series aims to inform and guide early career scientists interested in science policy. This series is brought to you by the GSA Early Career Scientist…

GSA announces a new funding opportunity for members.  In the ever-evolving landscape of scientific research, access to funding is often a significant hurdle for scientists and researchers. Recognizing our membership’s potential to create change and the need for funding, GSA has developed a new initiative: the Starter Culture Microgrant Program. Use funds to design your…

Show support for your MODs! GSA President Hugo Bellen and Vice-President E. Jane Hubbard are among the co-authors of a recent Perspectives article in Development titled “Model organism databases are in jeopardy.” The article describes the importance of model organism databases (MODs), the threat posed by NIH MOD budget cuts, and possible solutions. “We are…

Students, postdocs, academic faculty, and industry researchers will all find benefits at the new Industry Sessions at TAGC, to be held April 22–26 2020 in the Washington DC region. When industry scientists and academic labs collaborate, both society and science benefit. That’s one of two big-picture messages Kailene Simon hopes will be conveyed through a…

Executive Director and Scientific Advisor Kevin Lee works for several private foundations, bridging funding gaps by building networks of scientists, clinicians, and patients. In the Decoding Life series, we talk to geneticists with diverse career paths, tracing the many directions possible after research training. This series is brought to you by the GSA Early Career Scientist Career Development…

NSF Program Officer Chinonye Nnakwe Whitley combines her skills in business, academia and entrepreneurship to empower underrepresented scientists. In addition to her work on the  NSF EPSCoR (Established Program to Stimulate Competitive Research) team, she leads innovation training workshops for early career scientists. In the Decoding Life series, we talk to geneticists with diverse career paths, tracing…

An automated drug screening approach gives insight into rare NGLY1 deficiency. Sometimes, diagnosing and treating an illness is straightforward. Other times, the diagnosis is challenging while the treatment is simple—or vice versa. In the case of a rare disease like NGLY1 Deficiency, both diagnosis and treatment can feel unreachable. The complex challenges of rare diseases…

As a Principal at venture capital firm Canaan, Colleen Cuffaro works to identify biopharmaceutical companies that have the next big idea in drug development. In the Decoding Life series, we talk to geneticists with diverse career paths, tracing the many directions possible after research training. This series is brought to you by the GSA Early Career Scientist Career…

As night fell, astronomer Jean Jacques d’Ortous de Mairan watched a plant’s leaves, symmetrically arranged side-by-side on a stem, clamp shut. It was 1729, and he was studying the dramatic nocturnal movement of Mimosa pudica. Strangely, he found that the plant behaved the same way even when it wasn’t exposed to natural cycles of light…

President Trump has proposed crippling cuts to federally supported research —including a reduction of medical research funding by nearly a fifth—that would be a disaster not just for innovation, but for Americans’ health and economic prosperity. Cuts at this unprecedented scale would have both immediate and long-term consequences: Promising research projects abandoned, labs closed, and…